Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Chemical Biology Letters is Scopus-indexed (Q1, CiteScore 10.8), WoS ESCI. Published by ScienceIn Publishing.
Checked against the index lists dated .
ISSN 2347-9825Verify ISSN ↗
Publisher: ScienceIn Publishing
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Clinical Biochemistry | 14 / 124 | 89th | Q1 |
| Biochemistry | 51 / 448 | 88th | Q1 |
| Molecular Biology | 61 / 414 | 85th | Q1 |
| Biochemistry (medical) | 12 / 78 | 85th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–present, best quartile Q1, CiteScore 10.8.
Chemical Biology Letters is Q1 in Clinical Biochemistry (rank 14 of 124), Q1 in Biochemistry (rank 51 of 448) and Q1 in Molecular Biology (rank 61 of 414), by CiteScore 2025. It is ranked in 4 subject areas in all.
Chemical Biology Letters is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 10.8, which places it in quartile Q1 at the 89th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.653, quartile Q2, with an H-index of 18.
Chemical Biology Letters is published by ScienceIn Publishing. Its ISSN is 2347-9825.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Chemical Biology Letters has an h-index of 13 and a 2-year mean of 2.23 citations per paper (OpenAlex). Its Scopus CiteScore is 10.8, quartile Q1. On 2-year citations it ranks #59 of 121 Scopus journals in Clinical Biochemistry.
Chemical Biology Letters published 18 papers in 2025; its busiest recent year was 2021 with 38. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 89 research articles (2021–2026), authors are most often from India (67.5%), United States (6.6%) and South Korea (3.4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.